Updated hourlyHourly refreshWed, Sep 9, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
This Strategic Engagement is Designed to Strengthen NeuroThera’s U.S. Market Position, Visibility Among Key U.S. Federal Stakeholders, Reinforce the Clinical and Public ‑H ealth Importance of Advancing New Treatment Options for Adult Tourette Syndrome TEL AVIV, ISRAEL - September 2, 2026 ( NEWMEDIAWIRE ) - SciSparc Ltd. (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, today announced that it is pursuing U.S. Food and Drug Administration (“FDA”) Orphan Drug Designation covering SCI-110, its drug candidate for the treatment adults with Tourette Syndrome (“TS”), a rare condition that may qualify for Orphan Drug De
Sep 2 · 13:14·NewMediaWire
Healthcare
As emerging research illuminates tirzepatide's metabolic and anti-inflammatory effects, Emerge extends compassionate, medically supervised weight loss care from board-certified providers to women whose health needs reach far beyond a number on the scale. [PR.com]
Sep 2 · 13:04·PR.com
Finance · Healthcare
RAMAT GAN, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,591,738 American Depositary Shares (ADSs), having an exercise price of $5.00 per ADS, issued by Can-Fite in March 2026, at a reduced exercise price of $2.50 per ADS. The ADSs representing ordinary shares issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form F-3 (File No. 333-294760). The closing of the o
Sep 2 · 13:02·GlobeNewswire
SaaS · Healthcare
(PR-inside.com) Bundled Valenz solutions for surgeries, imaging, specialty infusions, and catastrophic care now fully integrated into HealthJoy's Benefits Operating System to drive additional 50%+ savings CHICAGO, IL / ACCESS Newswire / September 2, 2026 / HealthJoy, a benefits operating system for employers, today solidified its partnership with Vālenz Health® to connect health plan members with high-value care while controlling costs for self-funded employers. Through this integration, HealthJoy can now surface bundled care solutions from Valenz, including its Surgical and Imaging, Centers of Excellence (COE), and Infusion Therapy programs, ahead of members making potentially costly decisions for complex care needs. HealthJoy's proactive steerage ..
Sep 2 · 13:00·PR-Inside
Healthcare
(PR-inside.com) Board-certified orthodontist Brandon J. Hagan, DMD, brings more than a decade of regional experience to a new practice serving children, teens and adults. UPPER MARLBORO, MD / ACCESS Newswire / September 2, 2026 / Southern Maryland Orthodontic Studio opened its Upper Marlboro practice in August, 2026, and is now accepting new patients at 5020 Brown Station Rd #130, Upper Marlboro, MD 20772. The office combines advanced orthodontic technology with the serene, tranquil atmosphere Dr. Hagan envisioned for the patient experience. Dr. Hagan is a board-certified orthodontist with more than a decade of experience treating patients in Southern Maryland and the Washington, D.C. region. ..
Sep 2 · 13:00·PR-Inside
Healthcare
Bundled Valenz solutions for surgeries, imaging, specialty infusions, and catastrophic care now fully integrated into HealthJoy's Benefits Operating System to drive additional 50%+ savings
Sep 2 · 13:00·Newswire.com
Healthcare
Google is kicking off a multi-year partnership with Jimmy Donaldson, better known as MrBeast, across Gemini and Google Health.
Sep 2 · 13:00·mlpr-google
AI · SaaS
(PR-inside.com) Company Advances AI-Assisted Imaging Tools Designed to Help Users Track Possible Early Warning Signs and Visible Changes Over Time MESA, AZ / ACCESS Newswire / September 2, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today highlighted the public-health urgency behind continued development of its MDCE Melanoma Scan Beta platform - an AI-assisted imaging and body-map monitoring application designed to help users organize, compare, and review visible skin images over time. Melanoma remains one of the most consequential cancers in the United States. According to American Cancer Society estimates for 2026, about 112,000 new invasive melanomas are expected to be diagnosed this year, ..
Sep 2 · 12:57·PR-Inside
AI · Healthcare
Company Advances AI-Assisted Imaging Tools Designed to Help Users Track Possible Early Warning Signs and Visible Changes Over Time
Sep 2 · 12:57·Newswire.com
Healthcare
ML4 Foundation-supported program reaches historic first-in-human milestone for children with Mucolipidosis Type IV ATLANTA, Sept. 2, 2026 /PRNewswire/ -- The Mucolipidosis Type IV (ML4) Foundation announces that the U.S. Food and Drug Administration (FDA) has allowed an Investigational...
Sep 2 · 12:49·PR Newswire
Finance · AI
MBody AI’s hardware-agnostic platform was shortlisted alongside CrowdStrike, Lenovo and CVS Health in a category recognizing real-world AI deployment MBody AI’s hardware-agnostic platform was shortlisted alongside CrowdStrike, Lenovo and CVS Health in a category recognizing real-world AI deployment
Sep 2 · 12:35·GlobeNewswire
Finance · Healthcare
(PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / September 2, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced its participation in the following upcoming investors conferences and industry events. 2026 Cantor Global Healthcare Conference being held Wednesday, September 9th to Saturday, September 12th at the Waldorf Astoria in New York City. The Company will host a presentation at 9:10am ET on Friday, September 10th. The H.C. Wainwright 28th Annual Global Investment Conference being held Monday, September 14th to ..
Sep 2 · 12:31·PR-Inside